Diagnosis and management of catheter-related bloodstream infections due to Staphylococcus aureus

Internal Medicine Journal

Volumn 35, Issue SUPPL. 2, 2005, Pages

  Gosbell, I B ^a,b  

^a SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Bacteraemia; Catheter related infections; Intravenous line sepsis; Staphylococcus aureus

Indexed keywords

CEFALOTIN; CEFAZOLIN; DICLOXACILLIN; FLUCLOXACILLIN; PENICILLIN G; VANCOMYCIN; ANTIINFECTIVE AGENT;

AUSTRALIA; BACTERIAL ENDOCARDITIS; BACTERIAL GROWTH; BLOOD CULTURE; CATHETER INFECTION; CLINICAL FEATURE; GRAM NEGATIVE AEROBIC RODS AND COCCI; HEART VALVE PROSTHESIS; HUMAN; INFECTION RATE; INTRAVENOUS CATHETER; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; ALGORITHM; BACTEREMIA; CATHETERIZATION; MICROBIOLOGY; STAPHYLOCOCCUS INFECTION;

ALGORITHMS; ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETERIZATION; HUMANS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 33645834779     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1444-0903.2005.00979.x     Document Type: Review

References (174)

1. Mermel LA, Farr BM, Sherertz RJ, Raad II, O'Grady N, Harris JS et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32: 1249-68.
2. Jarvis WR. Nosocomial outbreaks: The Centres for Disease Control Hospital. Am J Med 1991; 91 Suppl 3B: 101S-6S.
3. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG et al. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 2002; 23: 759-69.
4. Kluger DM, Maki DG. The relative risk of intravascular device related bloodstream infections in adults. [abstract 1913]. Programs and Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA: American Society for Microbiology; 1999.
5. Thomas MG, Morris AJ. Cannula-associated Staphylococcus aureus bacteraemia: outcome in relation to treatment. Intern Med J 2005; 35: 319-30.
6. Rosen AB, Fowler VG Jr, Corey GR, Downs SM, Biddle AK, Li J et al. Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia. Ann Intern Med 1999; 130: 810-20.
7. Collignon PJ. Intravascular catheter associated sepsis: a common problem. The Australian Study on Intravascular Catheter Associated Sepsis. Med J Aust 1994; 161: 374-8.
8. Crump JA, Collignon PJ. Intravascular catheter-associated infections. Eur J Clin Microbiol Infect Dis 2000; 19: 1-8.
9. Maki DG. Infections caused by intravascular devices used for infusion therapy: pathogenesis, prevention, and management. In: Bisno AL, Waldvogel FA, eds. Infectious Associated with Indwelling Medical Devices, 2nd edn. Washington, DC: American Society for Microbiology; 1994: 155-212.
10. Gosbell IB. Central venous catheter-related infection: diagnosis and prevention. Lab Med Intern 1995; 12: 20-7.
11. Linares J, Sitges-Serra A, Garau A, Perez JL, Martin R. Pathogenesis of catheter sepsis: a prospective study with quantitative and semiquantitiative cultures of catheter hub and segments. J Clin Microbiol 1985; 21: 357-60.
12. Collignon P, Soni N, Pearson I, Sorrell T, Woods P. Sepsis associated with central vein catheters in critically ill patients. Intensive Care Med 1988; 14: 227-31.
13. Collignon PJ, Munro R, Sorrell TC. Systemic sepsis and intravenous devices. A prospective survey. Med J Aust 1984; 141: 345-8.
14. Gosbell IB, Duggan D, Breust M, Mulholland K, Gottlieb T, Bradbury R. Infection associated with central venous catheters: a prospective survey. Med J Aust 1995; 162: 210-13.
15. Vaudaux P, Pittet D, Haeberli A, Huggler E, Nydegger UE, Lew DP. Host factors selectively increase staphylococcal adherence on inserted catheters: a role for fibronectin and fibrinogen or fibrin. J Infect Dis 1989; 160: 865-75.
16. Raad II, Luna M, Khalil SA, Costerton JW, Lam C, Bodey GP. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 1994; 271: 1014-16.
17. Peters G, Locci R, Pulverer G. Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J Infect Dis 1982; 146: 479-82.
18. Mermel LA, Maki DG. Infectious complications of Swan-Ganz pulmonary artery catheters. Am J Respir Cit Care Med 1994; 149: 1020-36.
19. Maki DG, Ringer M. Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters - gauze, a transparent polyurethane dressing, and an iodophor-transparent dressing. JAMA 1987; 258: 2396-403.
20. Henderson DK. Bacteremia due to percutaneous intravascular devices. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. New York, NY: Churchill Livingstone; 2000: 2069-92.
21. Mermel LA, Maki DG. Epidemic bloodstream infections from hemodynamic pressure monitoring: signs of the times. Infect Control Hosp Epidemiol 1989; 10: 47-53.
22. Kovalevich D, Faubion W, Bender JM, Schaberg DR, Wesley JR. Association of parenteral nutrition catheter sepsis with urinary tract infection. J Parenter Enteral Nutr 1986; 10: 639-41.
23. Band JD, Maki DG. Safety of changing intravenous delivery systems at longer than 24-hour intervals. Ann Intern Med 1979; 91: 173-8.
24. Maki DG. Nosocomial bacteraemia - an epidemiologic overview. Am J Med 1981; 70: 719-32.
25. Solomon SL, Khabbaz RF, Parker RH, Anderson RL, Geraghyt MA, Furman RM et al. An outbreak of Candida parapsilosis bloodstream infections in patients receiving parenteral nutrition. J Infect Dis 1984; 149: 98-102.
26. Buchholz DH, Young VM, Friedman NR, Reilly JA, Mardiney MR Jr. Bacterial proliferation in platelet products stored at room temperature. N Engl J Med 1971; 285: 429-33.
27. Raviglione MC, Battan R, Pablos-Mendez A. Infections associated with Hickman catheters in patients with acquired immunodeficiency syndrome. Am J Med 1989; 86: 780-6.
28. Maki DG, Jarrett F, Sarafin HW. A semiquantitative culture method for identification of catheter-related infection in the burn patient. J Surg Res 1977; 22: 513-20.
29. Williams JF, Seneff MG, Friedman BC. Use of femoral venous catheters in critically ill adults: prospective study. Crit Care Med 1991; 19: 550-3.
30. Dahlberg PJ, Yutuc WR, Newcomer KL. Subclavian hemodialysis catheter infections. Am J Kidney Dis, 1986; 7: 421-7.
31. Kozeny GA, Venezio FR, Bansal VK, Vertuno LL, Hano JE. Incidence of subclavian dialysis catheter-related infections. Arch Intern Med 1984; 144: 1787-9.
32. Danker WM, Spector SA, Fierrer J, Davis CE. Malassezia fungemia in neonates and adults: complication of hyperalimentation. Rev Infect Dis 1987; 9: 743-53.
33. Freeman J, Goldmann DA, Smith NE, Sidebottom DG, Epstein MF, Platt R. Association of intravenous lipid emulsion and coagulase-negative staphylococcal bacteremia in neonatal intensive care units. N Engl J Med 1990; 323: 301-8.
34. Pearson ML, (HICPAC) HICPAC. Guideline for prevention of intravascular-device-related infections. Infect Control Hosp Epidemiol 1996; 17: 438-73.
35. Glynn A, Ward V, Wilson J, Charlett A, Cookson B, Taylor L et al. Hospital-Acquired Infections: Surveillance, Policies and Practice. London, UK: Public Health Laboratory Service; 1997.
36. Auricht E, Borgert J, Butler M, Cadwallader H, Collignon P, Eades M et al. Uniform national numerator definitions for infection control clinical indicators: surgical site infection and health-care related bloodstream infection. Aust Infect Control 1999; 4: 12-14.
37. McDonald P, Carnie J, Christ V, Collignon P, Kampen R, Masters C et al. Appendix 1. Consensus numerator definitions. In: Infection Control Guidelines for the Prevention of Transmission of Infectious Diseases in the Health Care Setting. Canberra: Commonwealth of Australia; 2004.
38. Gosbell IB, Newton PJ, Sullivan EA. Survey of blood cultures from five community hospitals in south-western Sydney, Australia, 1993-1994. Aust NZ J Med 1999; 29: 684-92.
39. Siegman-Igra Y, Anglim AM, Shapiro DE, Adal KA, Strain BA, Farr BM. Diagnosis of vascular catheter-related bloodstream infection: a meta-analysis. J Clin Microbiol 1997; 35: 928-36.
40. DesJardin JA, Falagas ME, Ruthazer R, Griffith J, Wawrose D, Schenkein D et al. Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer. Ann Intern Med 1999; 131: 641-7.
41. Maki DG, Weise MS, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 1977; 296: 1305-9.
42. Sherertz RJ, Heard SO, Raad II. Diagnosis of triple-lumen catheter infection: comparison of roll plate, sonification, and flushing methodologies. J Clin Microbiol 1997; 35: 641-6.
43. Collignon PJ, Soni N, Pearson IY, Woods WP, Munro R, Sorrell TC. Is semiquantitative culture of central vein catheter tips useful in the diagnosis of catheter-associated bacteremia? J Clin Microbiol 1986; 24: 532-5.
44. Collignon P, Chan R, Munro R. Rapid diagnosis of intravascular catheter-related sepsis. Arch Intern Med 1987; 147: 1609-12.
45. Zufferey J, Rime B, Francioli P, Bille J. Simple method for rapid diagnosis of catheter-associated infection by direct acridine orange staining of catheter tips. J Clin Microbiol 1988; 26: 175-7.
46. Collignon PJ, Munro R. Laboratory diagnosis of intravascular catheter associated sepsis. Eur J Clin Microbiol Infect Dis 1989; 8: 807-14.
47. Arnow PM, Quimosing EM, Beach M. Consequences of intravascular catheter sepsis. Clin Infect Dis 1993; 16: 778-84.
48. Peacock SJ, Eddleston M, Emptage A, King A, Crook DW. Positive intravenous line tip cultures as predictors of bacteraemia. J Hosp Infect 1998; 40: 35-8.
49. Fan ST, Teoh-Chan CH, Lau KF. Evaluation of central venous catheter sepsis by differential quantitative blood culture. Eur J Clin Microbiol Infect Dis 1989; 8: 142-4.
50. Gaur AH, Flynn PM, Giannini MA, Shenep JL, Hayden RT. Difference in time to detection: a simple method to differentiate catheter-related from non-catheter-related bloodstream infection in immunocompromised pediatric patients. Clin Infect Dis 2003; 37: 469-75.
51. Raad I, Hanna HA, Alakech B, Chatzinikolaou I, Johnson MM, Tarrand J. Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections. Ann Intern Med 2004; 140: 18-25.
52. Blot F, Schmidt E, Nitenberg G, Tancrede C, Leclercq B, Laplanche A et al. Earlier positivity of central venous versus peripheral blood cultures is highly predictive of catheter related sepsis. J Clin Microbiol 1998; 36: 105-9.
53. Blot F, Nitenberg G, Chachaty E, Raynard B, Germann N, Antoun S, et al. Diagnosis of catheter-related bacteremia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet 1999; 354: 1071-7.
54. Bozzetti F, Terno G, Bonfanti G. Prevention and treatment of central venous catheter sepsis by exchange via a guidewire. A prospective controlled trial. Ann Surg 1983; 198: 48-52.
55. Cobb DK, High KP, Saweyer RG, Sable CA, Adams RB, Lindley DA. A controlled trial of scheduled replacement o central venous and pulmonary-artery catheters. N Engl J Med 1992; 327: 1062-8.
56. Raad I. Intravascular-catheter-related infections. Lancet 1998; 351: 893-8.
57. Ringberg H, Thoren A, Lilja B. Metastatic complications of Staphylococcus aureus septicemia. To seek is to find. Infection 2000; 28: 132-6.
58. Chang FY, Macdonald BB, Peacock JE Jr, Musher DM, Triplett P, Mylotte JM et al. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine 2003; 82: 322-32.
59. Bonhoeffer J, Haeberle B, Schaad UB, Heininge U. Diagnosis of acute haematogenous osteomyelitis and septic arthritis: 20 years experience at the University Children's Hospital Basel. Swiss Med Wkly 2001; 131: 575-81.
60. Roder BL, Wandall DA, Frimodt-Moller N, Espersen F, Skinhoj P, Rosdahl VT. Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark. Arch Intern Med 1999; 159: 462-9.
61. Gottlieb GS, Fowler VG Jr, Kong LK, McClelland RS, Gopal AK, Marr KA et al. Staphylococcus aureus bacteremia in the surgical patient: a prospective analysis of 73 postoperative patients who developed Staphylococcus aureus bacteremia at a tertiary care facility. J Am Coll Surg 2000; 190: 50-7.
62. Robinson DL, Fowler VG, Sexton DJ, Corey RG, Conlon PJ. Bacterial endocarditis in hemodialysis patients. Am J Kidney Dis 1997; 30: 521-4.
63. Hartstein AI, Mulligan ME, Morthland VH, Kwok RY. Recurrent Staphylococcus aureus bacteremia. J Clin Microbiol 1992; 30: 670-4.
64. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30: 633-8.
65. Fowler VG Jr, Li J, Corey GR, Boley J, Marr KA, Gopal AK et al. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol 1997; 30: 1072-8.
66. Fowler VG Jr, Sanders LL, Kong LK, McClelland RS, Gottlieb GS, Li J et al. Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. Clin Infect Dis 1999; 28: 106-14.
67. Mathur G, Kelly J, Cranney G, Jones P. Role of Transthoracic Echocardiograph in Excluding Left Sided Infective Endocarditis in Staphylococcus aureus Bacteremia. Abstract 14.30, The Australasian Society for Infectious Diseases Inc., Annual Scientific Meeting. 2002.
68. Tehranzadeh J, Wong E, Wang F, Sadighpour M. Imaging of osteomyelitis in the mature skeleton. Radiol Clin North Am 2001; 39: 223-50.
69. Schauwecker DS. Osteomyelitis: diagnosis with In-111-labeled leukocytes. Radiology 1989; 171: 141-6.
70. Sutter CW, Shelton DK. Three-phase bone scan in osteomyelitis and other musculoskeletal disorders. Am Fam Phys 1996; 54: 1639-47.
71. Nigro ND, Bartynski WS, Grossman SJ, Kruljac S. Clinical impact of magnetic resonance imaging in foot osteomyelitis. J Am Pod Med Assoc 1992; 82: 603-15.
72. Mahnken AH, Bucker A, Adam G, Gunther RW. [MRI of osteomyelitis: sensitivity and specificity of STIR sequences in comparison with contrast-enhaned T1 spin echo sequences]. Rofo: Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 2000; 172: 1016-9.
73. Massoure PL, Constans J, Caudry M, Morlat P, Skopinski S, Beylot J et al. [Upper extremity deep venous thrombosis. 40 hospitalized patients]. [French]. J des Maladies Vasculaires 2000; 25: 250-5.
74. Povoski SP, Zaman SA. Selective use of preoperative venous duplex ultrasound and intraoperative venography for central venous access device placement in cancer patients. Ann Surg Oncol 2002; 9: 493-9.
75. Dhekne RD, Moore WH, Peters C, Dudrick SJ, Long SE. Upper extremity radionuclide venography in the diagnosis and management of venous disease associated with intravenous catheters. Angiology 1988; 39: 907-14.
76. Wells PS, Anderson DR, Rodger M, Forgie M, Kearon C, Dreyer J et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med 2003; 349: 1227-35.
77. Kao PF, Tsui KH, Leu HS, Tsai MF, Tzen KY. Diagnosis and treatment of pyogenic psoas abscess in diabetic patients: usefulness of computed tomography and gallium-67 scanning. Urology 2001; 57: 246-51.
78. Lee YT, Lee CM, Su SC, Liu CP, Wang TE. Psoas abscess: a 10 year review. J Microbiol Immunol Infect 1999; 32: 40-6.
79. Rello J, Coll P, Prats G. Evaluation of culture techniques for diagnosis of catheter-related sepsis in critically ill patients. Eur J Clin Microbiol Infect Dis 1992; 11: 1192-3.
80. Raad I, Davis S, Khan A, Tarrand J, Elting L, Bodey GP. Impact of central venous catheter removal on the recurrence of catheter- related coagulase-negative staphylococcal bacteremia. Infect Control Hosp Epidemiol 1992; 13: 215-21.
81. Dugdale DC, Ramsey PG. Staphylococcus aureus bacteremia in patients with Hickman catheters. Am J Med 1990; 89: 137-41.
82. Anonymous. Recommendations for preventing the spread of vancomycin resistance. Hospital Infection Control Practices Advisory Committee (HICPAC). Infect Control Hosp Epidemiol 1995; 16: 105-13.
83. Lodise TP, McKinnon PS, Swiderski L, Rybak MJ. Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003; 36: 1418-23.
84. Chambers HF. Parenteral antibiotics for the treatment of bacteremia and other serious staphylococcal infections. In: Crossley KB, Archer GL, eds. The Staphylococci in Human Disease. New York, NY: Churchill Livingstone; 1997: 583-601.
85. McGregor AR, Collignon PJ. Bacteraemia and fungaemia in an Australian general hospital - associations and outcomes. Med J Aust 1993; 158: 671-4.
86. Spicer WJ, Christiansen K, Currie BJ, Dartnell JGA, Ferguson JK, Garland SM et al. Therapeutic guidelines: Antibiotic, 12th edn. Melbourne, Australia: Therapeutic Guidelines Ltd; 2003.
87. Hamburger M. Treatment of bacterial endocarditis. Mod Treat 1964; 1: 1003-15.
88. Lerner PI, Weinstein L. Infective endocarditis in the antibiotic era. N Engl J Med 1966; 274: 388-93.
89. Rabinovich S, Smith IM, January LE. The changing pattern of bacterial endocarditis. Med Clin North Am 1968; 52: 1091-101.
90. Mylotte JM, McDermott C. Staphylococcus aureus bacteremia caused by infected intravenous catheters. Am J Infect Control 1987; 15: 1-6.
91. Raad I, Bodey G. Infectious complications of indwelling vascular catheters. Clin Infect Dis 1992; 15: 197-210.
92. Malanoski GJ, Samore MH, Pefanis A, Karchmer AW. Staphylococcus aureus catheter-associated bacteremia. Minimal effective therapy and unusual infectious complications associated with arterial sheath catheters. Arch Intern Med 1995; 155: 1161-6.
93. Fowler VG Jr, Olsen MK, Corey GR, Woods CW, Cabell CH, Reller LB et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 2003; 163: 2066-72.
94. Gaillard JL, Merlino R, Pajot N, Goulet O, Fauchere JL, Ricour C et al. Conventional and nonconventional modes of vancomycin administration to decontaminate the internal surface of catheters colonized with coagulase-negative staphylococci. J Parenter Enteral Nutr 1990; 14: 593-7.
95. Guggenbichler JP, Berchtold D, Allerberger F, Bonatti H, Hager J, Pfaller W et al. In vitro and in vivo effect of antibiotics on catheters colonized by staphylococci. Eur J Clin Microbiol Infect Dis 1992; 11: 408-15.
96. Simon VC, Simon M. Antibacterial activity of teicoplanin and vancomycin in combination with rifampicin, fusidic acid or fosfomycin against staphylococci on vein catheters. Scand J Infect Dis Suppl 1990; 72: 14-19.
97. Capdevila JA, Segarra A, Planes AM, Ramirez-Arellano M, Pahissa A, Piera L et al. Successful treatment of haemodialysis catheter-related sepsis without catheter removal. Nephrol Dial Trans 1993; 8: 231-4.
98. Mermel LA, Stolz S, Maki DG. Epidemiology and pathogenesis of infection with Swan-Ganz catheters. A prospective study using molecular epidemiology. Am J Med 1991; 91: 197-295S.
99. Messing B, Peitra-Cohen S, Debure A, Beliah M, Bernier JJ. Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. J Parenter Enteral Nutr 1988; 12: 185-9.
100. Messing B. Catheter-sepsis during home parenteral nutrition: use of the antibiotic-lock technique. Nutrition 1998; 14: 466-8.
101. Rao JS, O'Meara A, Harvey T, Breatnach F. A new approach to the management of Broviac catheter infection. J Hosp Infect 1992; 22: 109-16.
102. Ruiz-Valverde MP, Barbera JR, Segarra A, Capdevila JA, Evangelista A, Piera L. Successful treatment of catheter-related sepsis and extraluminal catheter thrombosis with vancomycin and fraxiparin without catheter removal. Nephron 1997; 75: 354-5.
103. Jones GR, Konsler GK, Dunaway RP. Urokinase in the treatment of bacteremia and candidemia in patients with right atrial catheters. Am J Infect Control 1996; 24: 160-6.
104. Atkinson JB, Chamberlin K, Boody BA. A prospective randomized trial of urokinase as an adjuvant in the treatment of proven Hickman catheter sepsis. J Pediatr Surg 1998; 33: 714-16.
105. Tobiansky R, Lui K, Dalton DM, Shaw P, Martin H, Isaacs D. Complications of central venous access devices in children with and without cancer. J Paediatr Child Health 1997; 33: 509-14.
106. Worthley LI. Treatment of central venous silastic catheter infections using hydrochloric acid. Anaesth Intensive Care 1982; 10: 314-18.
107. Kaufman J, Demas C, Stark K, Flancbaum L. Catheter-related septic central venous thrombosis - current therapeutic options. West J Med 1986; 145: 200-3.
108. Verghese A, Widrich WC, Arbeit RD. Central venous septic thrombophlebitis - the role of medical therapy. Medicince 1985; 64: 394-400.
109. Topiel MS, Bryan RT, Kessler CM, Simon GL. Treatment of silastic catheter-induced central vein septic thrombophlebitis. Am J Med Sci 1986; 291: 425-8.
110. Villani C, Johnson DH, Cunha BA. Bilateral suppurative thrombophlebitis due to Staphylococcus aureus. Heart Lung J Acute Crit Care 1995; 24: 342-4.
111. Andes DR, Urban AW, Acher CW, Maki DG. Septic thrombosis of the basilic, axillary, and subclavian veins caused by a peripherally inserted central venous catheter. Am J Med 1998; 105: 446-50.
112. Fry DE, Fry RV, Borzotta AP. Nosocomial blood-borne infection secondary to intravascular devices. Am J Surg 1994; 167: 268-72.
113. Nehme AE. Nutritional support of the hospitalized patients: the team concept. JAMA 1980; 243: 1906-8.
114. Eggimann P, Harbarth S, Constantin MN, Touveneau S, Chevrolet JC, Pittet D. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 2000; 355: 1864-8.
115. Sherertz RJ, Ely EW, Westbrook DM, Gledhill KS, Streed SA, Kiger B et al. Education of physicians-in-training can decrease the risk for vascular catheter infection. Ann Intern Med 2000; 132: 641-8.
116. Soifer NE, Borzak S, Edlin BR, Weinstein RA. Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med 1998; 158: 473-7.
117. Tomford JW, Hershey CO. The i.v. therapy team: impact on patient care and costs of hospitalization. NITA 1985; 8: 387-9.
118. Alonso-Echanove J, Edwards JR, Richards MJ, Brennan P, Venezia RA, Keen J et al. Effect of nurse staffing and antimicrobial-impregnated central venous catheters on the risk for bloodstream infections in intensive care units. Infect Cont Hosp Epidemiol 2003; 24: 916-25.
119. Fridkin SK, Pear SM, Williamson TH, Galgiani JN, Jarvis WR. The role of understaffing in central venous catheter-associated bloodstream infections. Infect Cont Hosp Epidemiol 1996; 17: 150-8.
120. Robert J, Fridkin SK, Blumberg HM, Anderson B, White N, Ray SM et al. The influence of the composition of the nursing staff on primary bloodstream infection rates in a surgical intensive care unit. Infect Control Hosp Epidemiol 2000; 21: 12-17.
121. Vicca AF. Nursing staff workload as a determinant of methicillin- resistant Staphylococcus aureus spread in an adult intensive therapy unit. J Hosp Infect 1999; 43: 109-13.
122. Boyce JM, Pittet D, Healthcare Infection Control Practices Advisory C, Force HSAIHHT. Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HIPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Am J Infect Control 2002; 30: S1-46.
123. Larson EL. APIC guideline for handwashing and hand antisepsis in health care settings. Am J Infect Control 1995; 23: 251-69.
124. Anonymous. National Nosocomial Infections Surveillance (NNIS) System report, data summary from October 1986-April 1998, issued June 1998. Am J Infect Control 1998; 26: 522-33.
125. Anonymous. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 1999; 27: 520-32.
126. Banerjee SN, Emori TG, Culver DH, Gaynes RP, Jarvis WR, Horan T et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med 1991; 91: 86S-9S.
127. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine. alcohol. and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991; 338: 339-43.
128. Garland JS, Buck RK, Maloney P, Durkin DM, Toth-Lloyd S, Duffy M et al. Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trial. Pediatr Infect Dis J 1995; 14: 510-16.
129. Mimoz O, Pieroni L, Lawrence C, Edouard A, Costa Y, Samii K et al. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients. Crit Care Med 1996; 24: 1818-23.
130. Maki DG, McCormack KN. Defatting catheter insertion sites in total parenteral nutrition is of no value as an infection control measure. Am J Med 1987; 83: 833-40.
131. Ahmed Z, Mohyuddin Z. Complications associated with different insertion techniques for Hickman catheters. Postgrad Med J 1998; 74: 104-7.
132. Goetz AM, Wagener MM, Miller JM, Muder RR. Risk of infection due to central venous catheters: effect of site of placement and catheter type. Infect Control Hosp Epidemiol 1998; 19: 842-5.
133. Clark-Christoff N, Watters VA, Sparks W, Snyder P, Grant JP. Use of triple-lumen subclavian catheters for administration of total parenteral nutrition. J Parenter Entertal Nutr 1992; 16: 403-7.
134. Early TF, Gregory RT, Wheeler JR, Snyder SO Jr, Gayle RG. Increased infection rate in double-lumen versus single-lumen Hickman catheters in cancer patients. South Med J 1990; 83: 34-6.
135. Yeung C, May J, Hughes R. Infection rate for single lumen v triple lumen subclavian catheters. Infect Control Hosp Epidemiol 1988; 9: 154-8.
136. Groeger JS, Lucas AB, Thaler HT, Friedlander-Klar H, Brown AE, Kiehn TE et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 1993; 119: 1168-74.
137. Pegues D, Axelrod P, McClarren C, Eisenberg BL, Hoffman JP, Ottery FD et al. Comparison of infections in Hickman and implanted port catheters in adult solid tumor patients. J Surg Oncol 1992; 49: 156-62.
138. Soo RA, Gosbell IB, Gallo JH, Harvey MP, Dunlop L, Motum P et al. Hickman catheter complications in a haematology unit, 1996-98. Intern Med J 2002; 32: 100-3.
139. Loewenthal MR, Dobson PM, Starkey RE, Dagg SA, Petersen A, Boyle MJ. The peripherally inserted central catheter (PICC): a prospective study of its natural history after cubital fossa insertion. Anaesth Intensive Care 2002; 30: 21-4.
140. Skiest DJ, Abbott M, Keiser P. Peripherally inserted central catheters in patients with AIDS are associated with a low infection rate. Clin Infect Dis 2000; 30: 949-52.
141. Anonymous. III. NKF-K/DOQI clinical practice guidelines for vascular access: update 2000. Am J Kidney Dis 2001; 37: S137-81.
142. Hoen B, Paul-Dauphin A, Hestin D, Kessler M. EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 1998; 9: 869-76.
143. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000; 132: 391-402.
144. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 1999; 281: 261-7.
145. Darouiche RO, Raad II, Heard SO, Thornby JI, Wenker OC, Gabrielli A et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med 1999; 340: 1-8.
146. McConnell SA, Gubbins PO, Anaissie EJ. Do antimicrobial-impregnated central venous catheters prevent catheter-related bloodstream infection? Clin Infect Dis 2003; 37: 65-72.
147. Ljungman P, Hagglund H, Bjorkstrand B, Lonnqvist B, Ringden O. Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized, controlled study. Support Care Cancer 1997; 5: 485-8.
148. McKee R, Dunsmuir R, Whitby M, Garden OJ. Does antibiotic prophylaxis at the time of catheter insertion reduce the incidence of catheter-related sepsis in intravenous nutrition? J Hosp Infect 1985; 6: 419-25.
149. Ranson MR, Oppenheim BA, Jackson A, Kamthan AG, Scarffe JH. Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. J Hosp Infect 1990; 15: 95-102.
150. Kacica MA, Horgan MJ, Ochoa L, Sandler R, Lepow ML, Venezia RA. Prevention of gram-positive sepsis in neonates weighing less than 1500 grams. J Pediatr 1994; 125: 253-8.
151. Spafford PS, Sinkin RA, Cox C, Reubens L, Powell KR. Prevention of central venous catheter-related coagulase-negative staphylococcal sepsis in neonates. J Pediatr 1994; 125: 259-63.
152. Carratala J, Niubo J, Fernandez-Sevilla A, Juve E, Castellsague X, Berlanga J et al. Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrob Agents Chemother 1999; 43: 2200-4.
153. Henrickson KJ, Axtell RA, Hoover SM, Kuhn SM, Pritchett J, Kehl SC et al. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: a randomized, multicenter, double-blind trial. J Clin Oncol 2000; 18: 1269-78.
154. Schwartz C, Henrickson KJ, Roghmann K, Powell K. Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. J Clin Oncol 1990; 8: 1591-7.
155. Boelaert JR, De Baere YA, Geernaert MA, Godard CA, Van Landuyt HW. The use of nasal mupirocin ointment to prevent Staphylococcus aureus bacteraemias in haemodialysis patients: an analysis of cost-effectiveness. J Hosp Infect 1991; 19: 41-6.
156. Hoffmann KK, Weber DJ, Samsa GP, Rutala WA. Transparent polyurethane film as an intravenous catheter dressing. A meta-analysis of the infection risks. JAMA 1992; 267: 2072-6.
157. Levin A, Mason AJ, Jindal KK, Fong IW, Goldstein MB. Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine. Kidey Int 1991; 40: 934-8.
158. Rao SP, Oreopoulos DG. Unusual complications of a polyurethane PD catheter. Perit Dial Int 1997; 17: 410-12.
159. Johnson DW, MacGinley R, Kay TD, Hawley CM, Campbell SB, Isbel NM et al. A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrol Dial Trans 2002; 17: 1802-7.
160. Annigeri R, Conly J, Vas S, Dedier H, Prakashan KP, Bargman JM et al. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit Dial Int 2001; 21: 554-9.
161. Josephson A, Gomber ME, Sierra MF, Karanfil LV, Tansino GF. The relationship between intravenous fluid contamination and the frequency of tubing replacement. Infect Control 1985; 6: 367-70.
162. Maki DG, Botticelli JT, LeRoy ML, Thielke TS. Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hous intervals. 72 hours is safe and costeffective. JAMA 1987; 258: 1777-81.
163. Snydman DR, Reidy MD, Perry LK, Martin WJ. Safety of changing intravenous (IV) administration sets containing burettes at longer than 48 hour intervals. Infect Control 1987; 8: 113-16.
164. Snydman DR, Donnelly-Reidy M, Perry LK, Martin WJ. Intravenous tubing containing burettes can be safely changed at 72 hour intervals. Infect Control 1987; 8: 113-16.
165. Eyer S, Brummitt C, Crossley K, Siegel R, Cerra F. Catheter-related sepsis: prospective. randomized study of three methods of long-term catheter maintenance. Crit Care Med 1990; 18: 1073-9.
166. Uldall PR, Merchant N, Woods F et al. Changing subclavian hemodialysis cannulas to reduce infection. Lancet 1981; 2: 1373.
167. Collin J, Collin C. Letter: infusion thrombophlebitis. Lancet 1975; 2: 458.
168. Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial. Ann Intern Med 1991; 114: 845-54.
169. Raad II, Hohn DC, Gilbreath BJ, Suleiman N, Hill LA, Bruso PA et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994; 15: 231-8.
170. Harvey MP, Trent RJ, Joshua DE, Ramsay-Stewart G, Storey DW, Kroneberg H. Complications associated with indwelling venous Hickman catheters in patients with haematological disorder. Aust NZ J Med, 1986; 16: 211-15.
171. Lokich JJ, Bothe A, Benotti P. Complications and management of implanted venous access catheters. J Clin Oncol 1985; 3: 710-17.
172. Graham DR, Keldermans MM, Klemm LW, Semenza NJ, Shafer ML. Infectious complications among patients receiving home intravenous therapy with peripheral, central, or peripherally placed central venous catheters. Am J Med 1991; 91: 95S-100S.
173. Rupp ME. Infections of intravascular catheters and vascular devices. In: Crossley KB, Archer GL, eds. The Staphylococci in Human Disease, 1st edn. New York, NY: Churchill Livingstone; 1997: 379-99.
174. Maki DG, Rhame FS, Mackel DC, Bennett JV. Nationwide epidemic of septicemia caused by contaminated intravenous products. Am J Med 1976; 60: 471-85.